EP0296227A4 - Verabreichung von aminosäuren durch die nase. - Google Patents

Verabreichung von aminosäuren durch die nase.

Info

Publication number
EP0296227A4
EP0296227A4 EP19880901000 EP88901000A EP0296227A4 EP 0296227 A4 EP0296227 A4 EP 0296227A4 EP 19880901000 EP19880901000 EP 19880901000 EP 88901000 A EP88901000 A EP 88901000A EP 0296227 A4 EP0296227 A4 EP 0296227A4
Authority
EP
European Patent Office
Prior art keywords
amino acids
nasal delivery
nasal
delivery
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19880901000
Other languages
English (en)
French (fr)
Other versions
EP0296227A1 (de
Inventor
Jeffrey Wenig
Jason Wenig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marina Biotech Inc
Original Assignee
MDRNA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MDRNA Inc filed Critical MDRNA Inc
Publication of EP0296227A4 publication Critical patent/EP0296227A4/de
Publication of EP0296227A1 publication Critical patent/EP0296227A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
EP88901000A 1987-01-08 1987-12-28 Verabreichung von aminosäuren durch die nase Withdrawn EP0296227A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US144887A 1987-01-08 1987-01-08
US1448 1987-01-08

Publications (2)

Publication Number Publication Date
EP0296227A4 true EP0296227A4 (de) 1988-11-29
EP0296227A1 EP0296227A1 (de) 1988-12-28

Family

ID=21696066

Family Applications (1)

Application Number Title Priority Date Filing Date
EP88901000A Withdrawn EP0296227A1 (de) 1987-01-08 1987-12-28 Verabreichung von aminosäuren durch die nase

Country Status (3)

Country Link
EP (1) EP0296227A1 (de)
JP (1) JPH01501708A (de)
WO (1) WO1988004926A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69831421T2 (de) 1997-12-02 2006-06-22 Archimedes Development Ltd. Zusammensetzungen zur nasalen verabreichung
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
JP2004123564A (ja) * 2002-09-30 2004-04-22 Inst Of Physical & Chemical Res 中枢機能改善用アミノ酸組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2666012A (en) * 1950-10-02 1954-01-12 Jr Edgar A Ferguson Nose drops
EP0115627A1 (de) * 1982-12-29 1984-08-15 Armour Pharmaceutical Company Steigerung der intranasalen Absorption von Calcitonin durch dessen Formulierung mit oberflächenaktiven Mitteln

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
US4414202A (en) * 1980-02-19 1983-11-08 Silvetti Anthony N Composition for treatment of wounds
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
US4604286A (en) * 1984-09-17 1986-08-05 Daigo Nutritive Chemicals, Ltd. Infusion solution for parenteral nutrition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2666012A (en) * 1950-10-02 1954-01-12 Jr Edgar A Ferguson Nose drops
EP0115627A1 (de) * 1982-12-29 1984-08-15 Armour Pharmaceutical Company Steigerung der intranasalen Absorption von Calcitonin durch dessen Formulierung mit oberflächenaktiven Mitteln

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8804926A1 *

Also Published As

Publication number Publication date
EP0296227A1 (de) 1988-12-28
WO1988004926A1 (en) 1988-07-14
JPH01501708A (ja) 1989-06-15

Similar Documents

Publication Publication Date Title
EP0296236A4 (de) Koffeinverabreichung durch die nase.
ZA857355B (en) Novel drug delivery system
GB8712176D0 (en) Drug delivery system
GB8519530D0 (en) Drug delivery system
GB8700851D0 (en) Drug delivery system
ZA87737B (en) Drug delivery system
EP0197504A3 (en) Ph-mediated drug delivery system
IL87688A (en) Fuel delivery system
GB8502156D0 (en) Drug delivery
EP0274896A3 (en) Hanky delivery system
GB2206046B (en) Multi-unit delivery system
ZA882347B (en) Amino acid derivatives
ZA887322B (en) Amino acid derivatives
EP0182502A3 (en) Drug delivery system
GB8702171D0 (en) Protein hydrolysates
IL88668A0 (en) Derivatives of cyclic amino acids,a process for the preparation thereof,agents containing them,and the use thereof
AU102141S (en) Nasal spray pump
EP0296227A4 (de) Verabreichung von aminosäuren durch die nase.
ZA887373B (en) Amino acid derivatives
EP0300737A3 (en) Calcitonin gene related peptide derivatives
ZA883782B (en) Amino acid derivatives
AU2185888A (en) Fuel delivery identification system
GB8707515D0 (en) Amino acid derivatives
IL83572A (en) Nasal pharmaceutical compositions comprising octreotide
IE872024L (en) N-(2-cyano-2-alkoxyiminoacyl) amino acids

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19880908

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NASTECH PHARMACEUTICAL COMPANY, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 19881129

17Q First examination report despatched

Effective date: 19900412

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19910723